Wellington Management Group’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
Other funds holding TSHA
Wellington Management Group's TSHA Position: Q3 2026 in Review
Wellington Management Group reduced its Taysha Gene Therapies (TSHA) stake by 3.8% in Q3 2026, selling an estimated $861K and leaving 3,826,272 shares worth $18.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1053.
Wellington Management Group first reported a position in TSHA in Q3 2020 and has held it in 10 quarters since. The position peaked at $27.1M in Q2 2026. 205 funds tracked by Wall St. Rank hold TSHA as of Q3 2026.
- Wellington Management Group held 3,826,272 shares of Taysha Gene Therapies worth $18.6M as of Q3 2026.
- Wellington Management Group sold 149,333 Taysha Gene Therapies shares in Q3 2026, an estimated $861K.
- Taysha Gene Therapies made up ﹤0.01% of Wellington Management Group's portfolio in Q3 2026, its #1053 holding.
- Wellington Management Group first reported a position in Taysha Gene Therapies in Q3 2020 and has held it in 10 quarters since.
- Wellington Management Group's Taysha Gene Therapies position peaked at $27.1M in Q2 2026.
- 205 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q3 2026.
Based on Wellington Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.